Work

Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.525

Authors: William John Gradishar, Mark E. Robson, Darl D Flake, Lee Steven Schwartzberg, Priyanka Sharma, Hatem Hussein Soliman, Anthony Martin Magliocco, Krystal Brown, Saskia Wehnelt, Alexander Gutin, Ralf Kronenwett, Johnathan M. Lancaster

Institutions: Northwestern University, Memorial Sloan Kettering Cancer Center, Myriad Genetics, University of Tennessee Health Science Center, West Cancer Center, University of Kansas Medical Center, Moffitt Cancer Center, Myriad (Germany), Federal Office of Administration

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2805950682

Cites:

Cited by: 2

Related to: 10